X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2572) 2572
Publication (343) 343
Patent (198) 198
Book Review (50) 50
Book Chapter (33) 33
Dissertation (4) 4
Book / eBook (2) 2
Magazine Article (2) 2
Paper (2) 2
Conference Proceeding (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1951) 1951
humans (1555) 1555
male (1244) 1244
non-alcoholic fatty liver disease (1204) 1204
animals (1056) 1056
fatty liver (905) 905
liver diseases (836) 836
obesity (722) 722
metabolic syndrome (715) 715
female (709) 709
liver (705) 705
insulin-resistance (704) 704
insulin resistance (668) 668
risk factors (627) 627
gastroenterology & hepatology (585) 585
liver - metabolism (573) 573
mice (570) 570
liver - pathology (539) 539
middle aged (509) 509
hepatic steatosis (475) 475
non-alcoholic fatty liver disease - metabolism (451) 451
inflammation (450) 450
nonalcoholic steatohepatitis (441) 441
steatohepatitis (438) 438
steatosis (429) 429
adult (424) 424
oxidative stress (415) 415
fatty liver-disease (407) 407
non-alcoholic fatty liver disease - prevention & control (401) 401
diet (394) 394
prevalence (386) 386
non-alcoholic fatty liver disease - pathology (385) 385
rodents (343) 343
mice, inbred c57bl (339) 339
liver - drug effects (334) 334
nutrition & dietetics (333) 333
metabolism (332) 332
disease models, animal (328) 328
fibrosis (327) 327
diabetes (326) 326
nutritional and metabolic diseases (298) 298
non-alcoholic fatty liver disease - etiology (291) 291
lipids (283) 283
nafld (283) 283
rats (280) 280
disease (277) 277
nonalcoholic fatty liver disease (274) 274
non-alcoholic fatty liver disease - epidemiology (272) 272
fatty acids (269) 269
digestive system diseases (268) 268
research (260) 260
body mass index (253) 253
medicine (246) 246
health aspects (244) 244
non-alcoholic steatohepatitis (242) 242
endocrinology & metabolism (240) 240
aged (233) 233
insulin (231) 231
analysis (229) 229
non-alcoholic fatty liver disease - complications (229) 229
research article (229) 229
fatty liver - prevention & control (224) 224
fatty liver - metabolism (222) 222
cholesterol (218) 218
lipid metabolism (217) 217
non-alcoholic fatty liver disease - drug therapy (217) 217
article (216) 216
gastroenterology and hepatology (213) 213
non-alcoholic fatty liver disease - blood (212) 212
review (211) 211
diet, high-fat - adverse effects (209) 209
gene expression (207) 207
biochemistry & molecular biology (203) 203
physiological aspects (201) 201
care and treatment (199) 199
foods or foodstuffs (198) 198
foods, foodstuffs, or non-alcoholic beverages, not covered bysubclasses a23b - a23j (198) 198
human necessities (198) 198
preservation of foods or foodstuffs, in general (198) 198
their preparation or treatment, e.g. cooking, modification ofnutritive qualities, physical treatment (198) 198
their treatment, not covered by other classes (198) 198
multidisciplinary sciences (197) 197
obesity - complications (196) 196
hygiene (194) 194
medical or veterinary science (193) 193
preparations for medical, dental, or toilet purposes (193) 193
studies (192) 192
non-alcoholic fatty liver disease - diagnosis (191) 191
risk (188) 188
type 2 diabetes (181) 181
digestive system (180) 180
prevention (180) 180
biomarkers - blood (177) 177
glucose (177) 177
fatty liver - pathology (176) 176
risk-factors (175) 175
expression (172) 172
non-alcoholic fatty liver disease - genetics (169) 169
cardiovascular-disease (166) 166
medicine, research & experimental (166) 166
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2699) 2699
Korean (81) 81
French (67) 67
Chinese (43) 43
German (26) 26
Japanese (23) 23
Russian (16) 16
Spanish (12) 12
Hungarian (7) 7
Persian (3) 3
Polish (3) 3
Portuguese (2) 2
Croatian (1) 1
Czech (1) 1
Danish (1) 1
Italian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Gastroenterology, ISSN 0016-5085, 2014, Volume 147, Issue 5, pp. 1073 - 1083.e6
Background & Aims Nonalcoholic fatty liver disease is a common consequence of human and rodent obesity. Disruptions in lipid metabolism lead to accumulation of... 
Gastroenterology and Hepatology | Fatty Acid Metabolism | Acyl-CoA | Long Chain Fatty Acid | Acid Acyl-CoA | Long Chain Fatty | PPAR-ALPHA | IMPROVES INSULIN SENSITIVITY | LIPID-METABOLISM | FIBROBLAST-GROWTH-FACTOR-21 | NONALCOHOLIC STEATOHEPATITIS | LIVER-DISEASE | OBESITY | ENERGY-EXPENDITURE | STEATOSIS | GASTROENTEROLOGY & HEPATOLOGY | FGF21 | Non-alcoholic Fatty Liver Disease - pathology | Liver - pathology | Fibroblast Growth Factors - genetics | Choline Deficiency - complications | RNA, Messenger - metabolism | Fibroblast Growth Factors - metabolism | Non-alcoholic Fatty Liver Disease - blood | Hepatitis - prevention & control | Time Factors | Fibroblast Growth Factors - administration & dosage | Hepatitis - genetics | Hepatitis - metabolism | Inflammation Mediators - metabolism | Lipid Peroxidation - drug effects | Liver Cirrhosis - metabolism | Fatty Acids - metabolism | Liver Cirrhosis - genetics | Disease Models, Animal | Methionine - deficiency | Severity of Illness Index | Liver Cirrhosis - prevention & control | Non-alcoholic Fatty Liver Disease - genetics | Oxidation-Reduction | Liver - metabolism | Mice, Inbred C57BL | Fibroblast Growth Factors - deficiency | Disease Progression | Recombinant Proteins - administration & dosage | Infusions, Subcutaneous | Mice, Knockout | Animals | Fibroblast Growth Factors - blood | Non-alcoholic Fatty Liver Disease - prevention & control | Liver diseases | Choline | Liver | Physiological aspects | Amino acids | Fibroblast growth factors | Triglycerides | Fatty acids | Index Medicus | Abridged Index Medicus | acyl-CoA | fatty acid metabolism | long chain fatty acid
Journal Article
Journal of Lipid Research, ISSN 0022-2275, 02/2013, Volume 54, Issue 2, pp. 345 - 357
It is important to clarify the distinct contributions of estrogen/estrogen receptor (ER) and androgen/androgen receptor (AR) signaling and their reciprocal... 
Estrogen receptor | Nonalcoholic steatohepatitis | Lipid metabolism | Androgen receptor | TESTOSTERONE REPLACEMENT | METABOLIC SYNDROME | estrogen receptor | ESTROGEN-RECEPTOR GENE | BIOCHEMISTRY & MOLECULAR BIOLOGY | lipid metabolism | MALE-MICE | nonalcoholic steatohepatitis | androgen receptor | REPRODUCTIVE FUNCTION | INSULIN-RESISTANCE | LATE-ONSET | AROMATASE | HEPATIC STEATOSIS | Estradiol - blood | Tumor Necrosis Factor-alpha - metabolism | Liver - pathology | Receptors, Estrogen - metabolism | Estrogens - pharmacology | Estrogens - deficiency | Fatty Liver - pathology | Humans | Middle Aged | Receptors, Androgen - metabolism | Body Weight - drug effects | Diet, High-Fat - adverse effects | Male | Estrogens - blood | Orchiectomy - adverse effects | Hydroxymethylglutaryl CoA Reductases - metabolism | Liver - drug effects | Androgens - blood | Dihydrotestosterone - blood | Non-alcoholic Fatty Liver Disease | Oxidation-Reduction - drug effects | Testosterone - deficiency | Dihydrotestosterone - pharmacology | Phosphorylation - drug effects | Estradiol - pharmacology | Cell Line | Interleukin-1 - metabolism | Fatty Liver - metabolism | Fatty Liver - blood | Liver - metabolism | Fatty Liver - prevention & control | Rats | Estradiol - deficiency | Down-Regulation - drug effects | Rats, Sprague-Dawley | Disease Progression | Organ Size - drug effects | Animals | Androgens - pharmacology | Signal Transduction - drug effects | Lipogenesis - drug effects | Aged | Cholesterol - biosynthesis | Acetyl-CoA Carboxylase - metabolism | Fatty Acids - biosynthesis
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 02/2016, Volume 11, Issue 2, p. e0147745
Nonalcoholic fatty liver disease (NAFLD), the hepatic manifestation of the metabolic syndrome, has become one of the most common causes of chronic liver... 
3T3-L1 ADIPOCYTES | POPULATION | OBESITY | ACID | MULTIDISCIPLINARY SCIENCES | CURCUMA-LONGA | PPAR-GAMMA | ALPHA | STEATOHEPATITIS | HEPATIC STEATOSIS | BISDEMETHOXYCURCUMIN | Choline - metabolism | Non-alcoholic Fatty Liver Disease - pathology | Curcumin - analogs & derivatives | Cholesterol - blood | Liver | Body Weight - drug effects | Non-alcoholic Fatty Liver Disease - etiology | Male | Alanine Transaminase - blood | Protective Agents - pharmacology | Choline Deficiency - metabolism | Silymarin - pharmacology | Methionine - deficiency | Liver Function Tests | Mice, Inbred C57BL | Curcumin - pharmacology | Curcumin - isolation & purification | Food, Formulated - adverse effects | Non-alcoholic Fatty Liver Disease - metabolism | Protective Agents - isolation & purification | Choline Deficiency - pathology | Choline Deficiency - prevention & control | Drug Synergism | Organ Size - drug effects | Animals | Aspartate Aminotransferases - blood | Lipogenesis - drug effects | Non-alcoholic Fatty Liver Disease - prevention & control | Triglycerides - blood | Mice | Curcuma - chemistry | Turmeric | Complications and side effects | Fatty liver | Diet | Physiological aspects | Dosage and administration | Research | Drug therapy | Developed countries | Animal models | Body weight | Kinases | Synergism | Rodents | Polyphenols | Curcumin | Lipogenesis | Medical research | Obesity | Liver diseases | Methionine | Metabolic diseases | Pharmacology | Bioavailability | Gene expression | Chemical compounds | Steatosis | Polymerase chain reaction | Cirrhosis | Silymarin | Choline | Fibrosis | Synergistic effect | Metabolic disorders
Journal Article
World Journal of Hepatology, ISSN 1948-5182, 2015, Volume 7, Issue 13, pp. 1788 - 1796
To review all of epidemiological aspects of non-alcoholic fatty liver disease (NAFLD) and also prevent this disease is examined. We conducted a systematic... 
Prevention | Metabolic risk factors | Non-alcoholic fatty liver disease | Asian countries | Systematic Reviews
Journal Article
Journal Article